Quick Overview: Elizabeth Plimack, MD, MS, of the Fox Chase Cancer Center, Philadelphia, PA talks about Ticiana A. Leal, MD, medical oncologist, ​team leader, University of Wisconsin Carbone Cancer Center Thoracic Malignancies ... Presented at SAYAO 2014 - Breaking Barriers in Acute Lymphoblastic Leukemia.

The Ecog Acrin E2810 Study - Detailed Overview & Context

Elizabeth Plimack, MD, MS, of the Fox Chase Cancer Center, Philadelphia, PA talks about Ticiana A. Leal, MD, medical oncologist, ​team leader, University of Wisconsin Carbone Cancer Center Thoracic Malignancies ... Presented at SAYAO 2014 - Breaking Barriers in Acute Lymphoblastic Leukemia. Uh my name is lynn wagner my name is lynn wagner i'm a co-pi of the iko acronym core Dr. Benson, Professor of Medicine, Northwestern University, tells us about the outcomes of In this segment, Dr. Mark R. Litzow provides an in-depth look at

Barbara Burtness, MD, Yale Cancer Center, New Haven, CT, USA, highlights data from Rick Baehner, MD, from Exact Sciences, discusses the significance of Exciting new data for metastatic renal cell carcinoma (mRCC) was presented at the American Society of Oncology (ASCO) 2018 ... Mark Litzow, MD, Mayo Clinic, Rochester, MN, shares the results of Mark Litzow, MD, Mayo Clinic Rochester, Rochester, MN, presents a case Pamela L. Kunz, MD, Yale University School of Medicine, New Haven, CT, reports on the final

Richard Simcock, MBBS, MCRP, FRCR, Brighton and Sussex University Hospital NHS Trust, Sussex, UK, highlights the ...

Photo Gallery

The ECOG-ACRIN E2810 study: pazopanib for patients with mRCC
KEYNOTE-604 and ECOG-ACRIN 5161 Trials for ES-SCLC
About ECOG-ACRIN
Dr. Leal on the Rationale for the ECOG-ACRIN EA5161 Trial in ES-SCLC
ALL in Adults: Perspectives from ECOG-Acrin & The Intergroup - Mark Litzow, MD
Resources & Support for Integrating PROs in ECOG-ACRIN Trials Webinar
Al Benson III, MD, FACP,  tells us about the outcomes of the ECOG-ACRIN study
ECOG-ACRIN E1910 Study On Blinatumomab In ALL Treatment – Dr. Mark R. Litzow
Reduced postoperative therapy in patients with OPC: ECOG-ACRIN 3311
Introducing the 2024 Young Investigator Award Recipient: Dustin Deming, MD
Advancing personalized breast cancer treatment: insights from ECOG-ACRIN E4112 and ADAPTcycle trials
Trial updates in mRCC from ASCO: KEYNOTE-427, RESORT, E2810 & IMmotion151
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored